Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1985 1
1989 2
1991 2
1993 1
1994 2
1995 4
1996 3
1997 1
1998 2
1999 2
2002 1
2003 1
2005 2
2012 1
2013 1
2014 2
2015 2
2016 1
2018 1
2019 3
2020 5
2021 2
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Epidemiology of heart failure.
Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Groenewegen A, et al. Eur J Heart Fail. 2020 Aug;22(8):1342-1356. doi: 10.1002/ejhf.1858. Epub 2020 Jun 1. Eur J Heart Fail. 2020. PMID: 32483830 Free PMC article. Review.
Near-home heart failure care.
Groenewegen A, Rutten FH. Groenewegen A, et al. Eur J Heart Fail. 2019 Jan;21(1):110-111. doi: 10.1002/ejhf.1345. Epub 2018 Dec 6. Eur J Heart Fail. 2019. PMID: 30520538 Free article. No abstract available.
Decelerating trends in heart failure survival.
Groenewegen A, Rutten FH. Groenewegen A, et al. Eur J Heart Fail. 2019 Nov;21(11):1326-1328. doi: 10.1002/ejhf.1626. Eur J Heart Fail. 2019. PMID: 31746110 Free article. No abstract available.
Diagnostic yield of a proactive strategy for early detection of cardiovascular disease versus usual care in adults with type 2 diabetes or chronic obstructive pulmonary disease in primary care in the Netherlands (RED-CVD): a multicentre, pragmatic, cluster-randomised, controlled trial.
Groenewegen A, Zwartkruis VW, Rienstra M, Zuithoff NPA, Hollander M, Koffijberg H, Oude Wolcherink M, Cramer MJ, van der Schouw YT, Hoes AW, Rutten FH, de Boer RA. Groenewegen A, et al. Lancet Public Health. 2024 Feb;9(2):e88-e99. doi: 10.1016/S2468-2667(23)00269-4. Epub 2023 Dec 19. Lancet Public Health. 2024. PMID: 38134944 Free article. Clinical Trial.
First-in-human clinical trial to assess pharmacokinetics, pharmacodynamics, safety, and tolerability of iscalimab, an anti-CD40 monoclonal antibody.
Espié P, He Y, Koo P, Sickert D, Dupuy C, Chokoté E, Schuler R, Mergentaler H, Ristov J, Milojevic J, Verles A, Groenewegen A, Auger A, Avrameas A, Rotte M, Colin L, Tomek CS, Hernandez-Illas M, Rush JS, Gergely P. Espié P, et al. Among authors: groenewegen a. Am J Transplant. 2020 Feb;20(2):463-473. doi: 10.1111/ajt.15661. Epub 2019 Dec 6. Am J Transplant. 2020. PMID: 31647605 Free article. Clinical Trial.
42 results